The U.S. Court of Appeals for the Second Circuit has reinstated a class action suit targeting unsolicited faxes that pharma giant Boehringer Ingelheim Pharmaceuticals Inc. allegedly sent to promote one of its medications.

The Second Circuit unanimously ruled that U.S. District Judge Stefan Underhill of the District of Connecticut erred in dismissing the suit brought by Physicians Healthsource Inc., an Ohio-based chiropractic clinic, stating that receiving unsolicited faxes promoting a free event for a drug that helps victims of a sexual disorder are “sufficient to state a claim.”

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]